google-site-verification: googlec7193c3de77668c9.html

New indicator for response to therapy in pediatric cancers identified

[
A study by researchers at the University of Birmingham has identified a new biomarker for response to a specific cancer therapy, treating children with Ewing Sarcoma and other tumor types. The study, which is a Phase I/II treatment arm within the eSMART Trial, was carried out at the Cancer Research UK Clinical Trials Unit (CRCTU), recruited 70 patients, and of those 66 were treated across four countries (the UK, France, the Netherlands and Spain). All these patients had solid tumors, 36 had Ewing Sarcoma and 34 had various other tumor types, mainly types of sarcoma and central nervous system tumors.


Source link

Advertisements
Views: 2

See also  Centiloid guidelines and recommendations released for clinical context-of-use in Alzheimer's disease

Check Also

Novel AI model accurately detects key gene mutations and predicts biomarkers across 32 cancer types

[ Input patches were extracted at 6× downsampling, corresponding to an approximate magnification of 6.7× …

Eclipse warning: All the key signs you may have damaged your eyes

Alexander Ionides, a consultant eye surgeon at Moorfields Eye Hospital in London says if you …

Did the eclipse damage your eyes? A surgeon explains

An eye surgeon says that fewer people have been seeking treatment for eye damage than …

Leave a Reply

Available for Amazon Prime
What is an elf bar, elf bar.